{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:54:42Z","timestamp":1779882882665,"version":"3.53.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10072-025-08803-6","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:44:58Z","timestamp":1771033498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and genetic spectrum of L-dopa responsive dystonia: insights from seven Egyptian cases"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-2505","authenticated-orcid":false,"given":"Nihal","family":"Almenabawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-1966","authenticated-orcid":false,"given":"Fawzia","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6548-6545","authenticated-orcid":false,"given":"Laila","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3300-040X","authenticated-orcid":false,"given":"Hebatallah M.","family":"Hassaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"8803_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","volume":"11","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne S, Jankovic J (2015) Dopa-responsive dystonia - clinical and genetic heterogeneity. Nat Rev Neurol 11:414\u2013424. https:\/\/doi.org\/10.1038\/nrneurol.2015.86","journal-title":"Nat Rev Neurol"},{"key":"8803_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.braindev.2010.10.015","volume":"33","author":"M Segawa","year":"2011","unstructured":"Segawa M (2011) Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 33:195\u2013201. https:\/\/doi.org\/10.1016\/j.braindev.2010.10.015","journal-title":"Brain Dev"},{"key":"8803_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/mds.870120321","volume":"12","author":"T Hanihara","year":"1997","unstructured":"Hanihara T, Inoue K, Kawanishi C et al (1997) 6-pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study. Mov Disord 12:408\u2013411. https:\/\/doi.org\/10.1002\/mds.870120321","journal-title":"Mov Disord"},{"key":"8803_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000021753","volume":"99","author":"H-Y Dong","year":"2020","unstructured":"Dong H-Y, Feng J-Y, Yue X-J et al (2020) Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Medicine (Baltimore) 99:e21753. https:\/\/doi.org\/10.1097\/md.0000000000021753","journal-title":"Medicine (Baltimore)"},{"key":"8803_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/mgme.2001.3213","volume":"74","author":"N Blau","year":"2001","unstructured":"Blau N, Bonaf\u00e9 L, Th\u00f6ny B (2001) Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of DOPA-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab 74:172\u2013185. https:\/\/doi.org\/10.1006\/mgme.2001.3213","journal-title":"Mol Genet Metab"},{"key":"8803_CR6","unstructured":"Furukawa Y (2019) GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia. In: GeneReviews\u00ae. pp 1\u201310"},{"key":"8803_CR7","unstructured":"Furukawa Y, Kish S (2017) Tyrosine Hydroxylase Deficiency. GeneReviews\u00ae. University of Washington, Seattle, pp 1\u201321"},{"key":"8803_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.22685","volume":"71","author":"J Friedman","year":"2012","unstructured":"Friedman J, Roze E, Abdenur JE et al (2012) Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy. Ann Neurol 71:520\u2013530. https:\/\/doi.org\/10.1002\/ana.22685","journal-title":"Ann Neurol"},{"key":"8803_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0022-510X(03)00129-1","volume":"213","author":"E Wilder-Smith","year":"2003","unstructured":"Wilder-Smith E, Tan EK, Law HY et al (2003) Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family. J Neurol Sci 213:25\u201328. https:\/\/doi.org\/10.1016\/S0022-510X(03)00129-1","journal-title":"J Neurol Sci"},{"key":"8803_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/mdc3.12144","volume":"2","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne S, Shulman JM, Jimenez-Shahed J et al (2015) SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia. Mov Disord Clin Pract 2:149\u2013154. https:\/\/doi.org\/10.1002\/mdc3.12144","journal-title":"Mov Disord Clin Pract"},{"key":"8803_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"8803_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/ana.21199","volume":"62","author":"MM Verbeek","year":"2007","unstructured":"Verbeek MM, Steenbergen-Spanjers GCH, Willemsen MAAP et al (2007) Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase gene. Ann Neurol 62:422\u2013426. https:\/\/doi.org\/10.1002\/ana.21199","journal-title":"Ann Neurol"},{"key":"8803_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/humu.22565","volume":"35","author":"A Fossbakk","year":"2014","unstructured":"Fossbakk A, Kleppe R, Knappskog PM et al (2014) Functional Studies of Tyrosine Hydroxylase Missense Variants Reveal Distinct Patterns of Molecular Defects in Dopa-Responsive Dystonia. Hum Mutat 35:880\u2013890. https:\/\/doi.org\/10.1002\/humu.22565","journal-title":"Hum Mutat"},{"key":"8803_CR14","first-page":"397","volume":"14","author":"AM Al-Muslamani","year":"2014","unstructured":"Al-Muslamani AM, Ali F, Mahmood F (2014) A new tyrosine hydroxylase genotype with orofacial dyskinaesia. SQU Med J 14:397\u2013400","journal-title":"SQU Med J"},{"key":"8803_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2025.1504744","volume":"16","author":"A Alakkas","year":"2025","unstructured":"Alakkas A, Shinawi H, Bajwa JA et al (2025) Retrospective chart review of inherited and idiopathic dystonia. Front Genet 16:1\u20139. https:\/\/doi.org\/10.3389\/fgene.2025.1504744","journal-title":"Front Genet"},{"key":"8803_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.644910","volume":"12","author":"XY Li","year":"2021","unstructured":"Li XY, Yang YM, Li LB et al (2021) Identification of TH Variants in Chinese Dopa-Responsive Dystonia Patients and Long-Term Outcomes. Front Neurol 12:1\u20138. https:\/\/doi.org\/10.3389\/fneur.2021.644910","journal-title":"Front Neurol"},{"key":"8803_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2017.01.019","volume":"644","author":"W Zhang","year":"2017","unstructured":"Zhang W, Zhou Z, Li X et al (2017) Dopa-responsive dystonia in Chinese patients: including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis. Neurosci Lett 644:48\u201354. https:\/\/doi.org\/10.1016\/j.neulet.2017.01.019","journal-title":"Neurosci Lett"},{"key":"8803_CR18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/mdc3.14157","volume":"11","author":"M Novelli","year":"2024","unstructured":"Novelli M, Tolve M, Quiroz V et al (2024) Autosomal recessive guanosine triphosphate cyclohydrolase I de ficiency\u202f: redefining the phenotypic spectrum and outcomes. Mov Disord 11:1072\u20131084. https:\/\/doi.org\/10.1002\/mdc3.14157","journal-title":"Mov Disord"},{"key":"8803_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ymgme.2014.10.014","volume":"114","author":"C Ortez","year":"2015","unstructured":"Ortez C, Duarte ST, Ormaz\u00e1bal A et al (2015) Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency. Mol Genet Metab 114:34\u201340. https:\/\/doi.org\/10.1016\/j.ymgme.2014.10.014","journal-title":"Mol Genet Metab"},{"key":"8803_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40734-017-0065-z","volume":"4","author":"LE Katus","year":"2017","unstructured":"Katus LE, Frucht SJ (2017) An unusual presentation of tyrosine hydroxylase deficiency. J Clin Mov Disord 4:1\u20135. https:\/\/doi.org\/10.1186\/s40734-017-0065-z","journal-title":"J Clin Mov Disord"},{"key":"8803_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/jmd2.12306","volume":"63","author":"M Champagne","year":"2022","unstructured":"Champagne M, Horvath GA, Perreault S et al (2022) Intermittent neurologic decompensation: an underrecognized presentation of tyrosine hydroxylase deficiency. JIMD Rep 63:400\u2013406. https:\/\/doi.org\/10.1002\/jmd2.12306","journal-title":"JIMD Rep"},{"key":"8803_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelekin.2019.102362","author":"M Nojszewska","year":"2019","unstructured":"Nojszewska M, Lusakowska A, Gawel M et al (2019) The needle EMG findings in myotonia congenita. J Electromyogr Kinesiol. https:\/\/doi.org\/10.1016\/j.jelekin.2019.102362","journal-title":"J Electromyogr Kinesiol"},{"key":"8803_CR23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/S0022-3476(00)90027-1","volume":"136","author":"C Dionisi-Vici","year":"2000","unstructured":"Dionisi-Vici C, Hoffmann GF, Leuzzi V et al (2000) Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy. J Pediatr 136:560\u2013562. https:\/\/doi.org\/10.1016\/S0022-3476(00)90027-1","journal-title":"J Pediatr"},{"key":"8803_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jnc.14624","volume":"148","author":"PD Szigetvari","year":"2019","unstructured":"Szigetvari PD, Muruganandam G, Kallio JP et al (2019) The quaternary structure of human tyrosine hydroxylase: effects of dystonia-associated missense variants on oligomeric state and enzyme activity. J Neurochem 148:291\u2013306. https:\/\/doi.org\/10.1111\/jnc.14624","journal-title":"J Neurochem"},{"key":"8803_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF et al (2019) Predicting splicing from primary sequence with deep learning. Cell 176:535-548.e24. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015","journal-title":"Cell"},{"key":"8803_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434\u2013443. https:\/\/doi.org\/10.1038\/s41586-020-2308-7","journal-title":"Nature"},{"key":"8803_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00702-021-02329-9","volume":"128","author":"J Pozojevic","year":"2021","unstructured":"Pozojevic J, Beetz C, Westenberger A (2021) The importance of genetic testing for dystonia patients and translational research. J Neural Transm 128:473\u2013481. https:\/\/doi.org\/10.1007\/s00702-021-02329-9","journal-title":"J Neural Transm"},{"key":"8803_CR28","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/mds.25382","volume":"28","author":"R Pons","year":"2013","unstructured":"Pons R, Syrengelas D, Youroukos S et al (2013) Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency. Mov Disord 28:1058\u20131063. https:\/\/doi.org\/10.1002\/mds.25382","journal-title":"Mov Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08803-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:36:30Z","timestamp":1774074990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08803-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["8803"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08803-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consents were obtained from all patients who participated in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}